ID: ALA547471

Max Phase: Preclinical

Molecular Formula: C22H17N5S

Molecular Weight: 383.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1ccc(-c2cccc(Nc3ccnc4cc(-c5nccs5)ccc34)c2)n1

Standard InChI:  InChI=1S/C22H17N5S/c1-27-11-8-19(26-27)15-3-2-4-17(13-15)25-20-7-9-23-21-14-16(5-6-18(20)21)22-24-10-12-28-22/h2-14H,1H3,(H,23,25)

Standard InChI Key:  XXOXSVINRAKDIU-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 383.48Molecular Weight (Monoisotopic): 383.1205AlogP: 5.50#Rotatable Bonds: 4
Polar Surface Area: 55.63Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.95CX LogP: 4.72CX LogD: 4.59
Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.44Np Likeness Score: -1.98

References

1. Simon Townson and Suzanne Gokool. GlaxoSmithKline Published Kinase Inhibitor Set 2 Onchocerca lienalis Screening Data,  [10.6019/CHEMBL3988181]